Internal Medicine · Royston, GA
NPI
1073603239
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
132 Franklin Springs St
Royston, GA, 30662
Phone (706) 245-7371
Groups this clinician bills Medicare through
Medicare paid, 2024
$490K
8,249 services
Medicare patients, 2024
804
Average age 76
Drug cost, 2024
$5.4M
113,939 prescriptions
Company payments, 2025
$1,542
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashok Kancharla was code 99308 (snf e&m), 2,461 times for 304 patients. In total Ashok Kancharla billed 8,249 services in 89 codes, and Medicare paid $490K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 2,461 | 304 | $54.90 | $135K |
| 99309 SNF E&M | Facility | 1,194 | 269 | $79.25 | $95K |
| 99214 Office E&M - Established | Office | 1,140 | 383 | $79.13 | $90K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 402 | 105 | $45.14 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 262 | 262 | $128.85 | $34K |
| 99497 Care Management/Coordination | Office | 256 | 255 | $81.48 | $21K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 254 | 254 | $18.26 | $4,639 |
| 99306 SNF E&M | Facility | 182 | 170 | $132.89 | $24K |
| 99213 Office E&M - Established | Office | 173 | 124 | $61.05 | $11K |
| 99457 E&M - Miscellaneous | Office | 93 | 21 | $36.11 | $3,358 |
| G0008 Administration of influenza virus vaccine | Office | 92 | 87 | $29.40 | $2,705 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 92 | 84 | $12.91 | $1,187 |
| 36415 Venipuncture Blood Collection | Office | 85 | 45 | $8.55 | $727 |
| 90662 Vaccine Product | Office | 81 | 77 | $80.48 | $6,519 |
| 81002 Clinical Chemistry | Office | 72 | 51 | $3.32 | $239 |
By year: 2022 $512K for 9,701 services; 2023 $515K for 8,480 services; 2024 $490K for 8,249 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 85 | 45 | $8.55 | $727 |
| 81002 Clinical Chemistry | 72 | 51 | $3.32 | $239 |
| 87804 Immunoassay | 26 | 12 | $16.22 | $422 |
| 83036 Blood Count | 23 | 21 | $9.52 | $219 |
| 87426 Immunoassay | 21 | 19 | $34.62 | $727 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashok Kancharla prescribed most often to Medicare patients was Rosuvastatin Calcium, with 5,361 prescriptions and refills. In total Ashok Kancharla wrote 113,939 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 5,361 | 6,293 | 351 | $39K |
| Amlodipine Besylate Generic | 4,118 | 5,053 | 303 | $19K |
| Levothyroxine Sodium Generic | 3,920 | 4,523 | 230 | $26K |
| Gabapentin Generic | 3,678 | 4,051 | 230 | $30K |
| Potassium Chloride Generic | 3,438 | 3,892 | 248 | $53K |
| Furosemide Generic | 3,064 | 3,582 | 263 | $14K |
| Omeprazole Generic | 2,726 | 3,115 | 210 | $19K |
| Famotidine Generic | 2,697 | 2,910 | 152 | $18K |
| Eliquis Apixaban | 2,320 | 2,432 | 134 | $519K |
| Escitalopram Oxalate Generic | 2,259 | 2,482 | 134 | $13K |
| Metoprolol Tartrate Generic | 2,221 | 2,450 | 119 | $11K |
| Donepezil Hcl Generic | 2,058 | 2,118 | 80 | $12K |
| Metoprolol Succinate Generic | 1,983 | 2,386 | 141 | $16K |
| Pantoprazole Sodium Generic | 1,966 | 2,697 | 225 | $17K |
| Lisinopril Generic | 1,802 | 2,279 | 164 | $9,928 |
Brand drugs: 14,639 claims; generic drugs: 99,029 claims; opioid claims: 2,714.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashok Kancharla $1,542 ($1,542 in general payments such as food, travel and fees) from 19 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $294.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $294 |
| Novo Nordisk Inc NVO | 10 | $271 |
| Abbvie Inc. ABBV | 18 | $231 |
| Axsome Therapeutics, Inc. AXSM | 7 | $128 |
| Lilly USA, LLC LLY | 5 | $87.75 |
| Amgen Inc. AMGN | 4 | $73.42 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $72.61 |
| GlaxoSmithKline, LLC. GSK | 3 | $70.24 |
| Pfizer Inc. PFE | 3 | $60.63 |
| Lundbeck LLC | 2 | $59.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.